Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-05

Clinical Trial Update: EEG Biomarker Study for Participants in the Neurolief "MOOD" Trial

View source ↗

Summary

This update describes an EEG biomarker study conducted with participants in the Neurolief MOOD trial for depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Butler Hospital | Conditions: Depression | Status: ACTIVE_NOT_RECRUITING